Logo Logo
Switch Language to German
Baumann, M.; Sahin, K.; Lechner, C.; Hennes, E. M.; Schanda, K.; Mader, S.; Karenfort, M.; Selch, C.; Häusler, M.; Eisenkölbl, A.; Salandin, M.; Gruber-Sedlmayr, U.; Blaschek, Astrid; Kraus, V.; Leiz, S.; Finsterwalder, J.; Gotwald, T.; Kuchukhidze, G.; Berger, T.; Reindl, M.; Rostasy, K. (2015): Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. In: Journal if neurology, neurosurgery and psychiatry, Vol. 86, No. 3: pp. 265-272


Background Myelin oligodendrocyte glycoprotein (MOG) antibodies have been recently described in children with acute disseminating encephalomyelitis (ADEM), but the clinical and neuroradiological characterisation of this subgroup is lacking. Objective To compare the clinical and neuroradiological features of paediatric ADEM with and without MOG antibodies. Methods Clinical course, cerebrospinal fluid (CSF)-, MRI studies, outcome and MOG status of 33 paediatric ADEM prospectively studied were reviewed. Results MOG antibodies (median 1: 2560; range 1: 160-1: 20 480) were detected in 19 children with ADEM. The majority of children showed a decline of serum MOG-IgG titres over time. Children with MOG antibodies did not differ in their age at presentation, sex ratio, the presence of oligoclonal bands, clinical symptoms or initial severity, apart from a